2015
DOI: 10.1021/id5000458
|View full text |Cite
|
Sign up to set email alerts
|

Benzothiazole and Pyrrolone Flavivirus Inhibitors Targeting the Viral Helicase

Abstract: The flavivirus nonstructural protein 3 (NS3) is a protease and helicase, and on the basis of its similarity to its homologue encoded by the hepatitis C virus (HCV), the flavivirus NS3 might be a promising drug target. Few flavivirus helicase inhibitors have been reported, in part, because few specific inhibitors have been identified when nucleic acid unwinding assays have been used to screen for helicase inhibitors. To explore the possibility that compounds inhibiting NS3-catalyzed ATP hydrolysis might functio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
55
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 53 publications
(55 citation statements)
references
References 59 publications
0
55
0
Order By: Relevance
“…The compound had low cytotoxicity, inhibited viral replication of DENV-1-4 and YFV (but not WNV or JEV) in various cell types, and reduced viral load in a mouse model of DENV infection 156 . A pyrrolone derivative (compound 25) inhibited WNV and DENV replication in cell culture, albeit with low selectivity index values, by targeting helicasecatalysed ATP hydrolysis, but had no effect on HCV helicase 157 . Ivermectin has also demonstrated inhibitory activity against YFV, DENV-2 and WNV helicases in the upper nanomolar range 158 , and is a weak inhibitor of DENV protease 159 , as discussed in detail below.…”
Section: Target Assaysmentioning
confidence: 99%
“…The compound had low cytotoxicity, inhibited viral replication of DENV-1-4 and YFV (but not WNV or JEV) in various cell types, and reduced viral load in a mouse model of DENV infection 156 . A pyrrolone derivative (compound 25) inhibited WNV and DENV replication in cell culture, albeit with low selectivity index values, by targeting helicasecatalysed ATP hydrolysis, but had no effect on HCV helicase 157 . Ivermectin has also demonstrated inhibitory activity against YFV, DENV-2 and WNV helicases in the upper nanomolar range 158 , and is a weak inhibitor of DENV protease 159 , as discussed in detail below.…”
Section: Target Assaysmentioning
confidence: 99%
“…In addition, pyrrolone specifically inhibits NS3 capacity to cleave ATP, as well as 50% of DENV and WNV (subtype Kunjin) replication in cells [57]. …”
Section: Helicase Domain Inhibitorsmentioning
confidence: 99%
“…Cytotoxicity in cell culture is unknown.Peptide WCW-NH2DENVPrusis et al, 2013 [50]Peptide WCW-NH2 inhibited protease in the four serotypes.ARDP0006 and ARDP0009DENVTonlimson and Watowich, 2011 [51]ARDP0006 and ARDP0009 inhibited DENV-2 virus replication in cell culture. Promising compounds for future research.AprotininDENVNoble et al, 2010 [53]Aprotinin envelops the enzyme and prevents the substrate from accessing the protease active site.NS3- HelicasEHalogenated benztriolesWNVSampath and Padmanabhan 2009 [3]Halogenated benztrioles were good, and selective inhibitor of the West Nile virus.IvermectinDENV, JEV, YFVMastrangelo et al, 2012 [55]; Sweeney et al, 2015 [57]Promising compound as the first specific therapy against flaviviruses (patent application EP2010/065880).ST-610DENVLim et al, 2013a [38]; Sweeney et al, 2015 [57]ST610 potently and selectively inhibited all four DENV serotypes in cell culture. For future trials, the pharmacokinetic properties of this compound should be improved.SuraminDENVBasavannacharya, Vasudeban, 2014 [58]; Sweeney et al, 2015 [57]Suramin acted as a potent NS3 helicase inhibitor of dengue virus by a non-competitive mode of inhibition.Analogues ML283DENVSweeney et al, 2015 [57]Analogues ML28331 were potent inhibitors of DENV NS3- catalyzed ATP hydrolysis.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Also, the close proximity of the two pockets may lend to the design of inhibitors that can span both sites. Several inhibitors have been reported for DENV helicase 19 . It will be interesting to see if they bind the ZIKV helicase and mitigate the ability of the virus to replicate.…”
mentioning
confidence: 99%